
Research explores how HIV is able to evolve during antiretroviral therapy.
Research explores how HIV is able to evolve during antiretroviral therapy.
Empliciti is an immunostimulatory antibody that targets the Signaling Lymphocyte Activation Molecule Family member 7.
Optogenetics technique harnesses immune system to reduce tumor size and metastasis.
Study finds the greatest access to cost-sharing reduction subsidies translated to the lowest costs for patients with HIV.
CVS program indicates option of in-store pickup or home delivery improved adherence rates.
Updated guidelines seek to decrease the risk of residual exposure to potentially dangerous medications.
CVS program indicates option of in-store pickup or home delivery improved adherence rates.
Treatment delivers miRNA to late-stage liver cancer tumors with low toxicity.
Engineered variants of neurochemical endomorphin could potentially relieve pain without causing drug addiction.
Obesity-related chronic diseases are a primary driver of higher costs in the Medicare system.
A patient discusses her courageous battle with familial amyotrophic lateral sclerosis.
Women diagnosed with malignant melanoma during pregnancy or within 1 year of giving birth were 5.1 times as likely to die.
Study indicates nearly 12,000 deaths related to the liver could be prevented from routine HCV screenings.
Intestinal gases colon cancer, irritable bowel syndrome, and inflammatory bowel disease.
Afatinib showed significant improvement in progression-free survival and objective response rate in non-small cell lung cancer patients.
Dinutuximab is the first immunotherapy approved for the treatment of a pediatric cancer.
Afatinib showed significant improvement in progression-free survival and objective response rate in non-small cell lung cancer patients.
Researchers seek to determine the ideal duration between radiation treatment and the actual surgical removal of cancerous cells.
Nisin shows promise in killing cancer and deadly bacteria resistant to antibiotics.
Dexilant SoluTab is a delayed-release orally disintegrating tablet that treats heartburn associated with GERD.
Personally-controlled health records have been prevented from adoption due to provider-based electronic health records.
Findings may lead to new treatment that protects nerves from damage caused in optic neuritis and throughout the central nervous system during MS attacks.
Newly identified biomarker may help determine whether patients will need chemotherapy post-surgery.
Adcetris is currently the only approved molecular-targeted therapy for Hodgkins lymphoma.
Study is the first to show a decrease in migraine frequency from medical marijuana.
Sovaldi tops the list of highest total annual drug spending by user.
Halaven treats liposarcoma patients who received prior chemotherapy that contained an anthracycline drug.
Venetoclax is an inhibitor of the B-cell lymphoma-2 protein in previously untreated AML patients.
Lynparza is a first in class PARP inhibitor for the monotherapy treatment of patients with metastatic castration resistant prostate cancer.
Halaven treats liposarcoma patients who received prior chemotherapy that contained an anthracycline drug.